ArticleTherapeutic advances in musculoskeletal disease2022

Effectiveness and safety of a biosimilar-to-biosimilar switch of the TNF inhibitor etanercept in patients with chronic inflammatory rheumatic diseases.

Uta Kiltz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.